Conceptualization and Scope of Emergent Drugs in Full Progression in this Century
DOI:
https://doi.org/10.53555/nnmhs.v4i11.601Keywords:
concepts of drugs emergent, new substances psychoactive, club drugs,, synthesis drugs, intelligent drugsAbstract
The world of the drugs is in constant growth and transformation. They incorporate to those that have existed from remote times, more and new, but even more dangerous and more addictive, and simultaneously multiple and new concepts are formulated that hinder its demarcation and learning. Objectives: To debate the precision of the main concepts on emergent or equivalent drugs, emitted in the last 10 years and, to contain novel aspects of the reach. Material and methods: It was made during the first semester of 2017, in Havana, Cuba, an orderly revision of information related with the concepts on emergent drugs and their reach, by means of electronic searches in libraries of magazines national doctors and indexed foreigners, as well as in texts, in the last 10 years. Development: When subjecting to the analysis these concepts, it was appreciated that they were restricted and imprecise that didn't pay to the prevention and that could generate until confusion. One kept in mind the reach of the novelty of these substances, and when paying attention to the great quantity of compounds that were not contemplated in precedent definitions, it was emitted, for the author with integrative premeditation, one new. onclusions: Drugs growth that circulate in this Century has been so dynamic, enormous, precipitate and excessively quickly, diverse for origin, composition and geographical unequal distribution that have been hindered its conceptualization, where the new, its reach, turns drugs riskier and unknowns, also invasive and additives, that allowed to contribute a comprehensive as a new whole concept.
References
2. Nuevas sustancias psicoactivas. Las drogas emergentes. Editora Centinela del Departamento de Ciencia Y tecnología del Ministerio del Interior, La Habana, 2017.
3. Nuevas Sustancias Psicoactivas. Las drogas emergentes. Curso de posgrado realizado en el Centro de Investigaciones Médico Quirúrgicas. [CD-ROM: Memorias de Salud Mental 2015, ISBN 978-959-306-156-8], CENSAM, Oct 12, 2015.
4. Drogas Emergentes: conocimientos más relevantes. Revista Hosp Psiquiátrico de la Habana (Suplemento Especial), ISSN – 0138-7103, 2016.
5. Características generales de los principales grupos de Drogas Emergentes: catinonas, piperacinas y spices. Revista Hosp Psiquiátrico de la Habana (Suplemento Especial), ISSN – 0138-7103, 2016.
6. Naciones Unidas: Junta Internacional de Fiscalización de Estupefacientes. Informe de la Junta Internacional de Fiscalización de Estupefacientes correspondiente a 2010. Disponible en URL: http://www.incb.org/pdf/annual-report/2010/es/Spanish_pdf.pdf. Consultado: 18/07/2018.
7. National Institute on Drug Abuse. Panorama Actual en el Uso de Drogas Emergentes. Health and Addictions: Vol. 14, No.1, 47-58. Recuperado de: http://www.drugabuse.gov/. Consultado: 12/07/2018.
8. Organización de Naciones Unidas (ONU). Oficina de las Naciones Unidas contra la Droga y el Delito (ONUDD). Informe mundial sobre las Drogas 2011. Viena. Disponible en: www.unodc.org/unodc/en/data-and-analysis/WDR-2011.html. Consultado: 12/04/2018.
9. United Nations Office on Drugs and Crime (2013). The Challenge of New Psychoactive Substances. The vaults of Erowid. Recuperado de: http: //www.eurowid.org, disponible en: http://www.unodc.org/documents/scientific/NPS_2013_SMART.pdf. Consultado: 12/06/2018.
10. Observatorio Europeo de las drogas y las Toxicomanías. Informe anual 2010. El problema de la drogodependencia en Europa. Luxemburgo: Oficina de publicaciones de la Unión Europea, 2010; 106-107. Disponible en:http://www.emcdda.europa.eu/attachements.cfm/att_120104_ES_EMCDDA_AR2010_ES.pdf . Consultado: 16/02/2018.
11. Observatorio Europeo de las Drogas y las Toxicomanías. Informe anual 2012. El problema de la drogodependencia en Europa. Luxemburgo: Oficina de Publicaciones de la Unión Europea 2012. Disponible en:
http://www.emcdda.europa.eu/attachements.cfm/att_190854_ES_TDAC12001ESC_.pdf. Consultado: 16/02/2018.
12. Observatorio Europeo de las Drogas y las Toxicomanías. Informe Europeo sobre Drogas 2013. Tendencias y novedades. Luxemburgo: Oficina de Publicaciones de la Unión Europea. Disponible en: http://www.emcdda.europa.eu/attachements.cfm/att_213154_ES_TDAT13001ESN1.pdf. Consultado: 18/01/2018.
13. Burillo-Putze G, Díaz BC, Pazos JL, Mas PM, Miró O, Puiguriguer J, et al. Drogas Emergentes (I): smart drugs. An Sist Sanit Navar 2011; 34: 263-274.
14. Burillo-Putze G, Domínguez A, Nogué S. Letter by Burillo-Putze et al regarding article, “acute coronary syndrome and khat herbal amphetamine use: an observational report”. Circulation 2012; 126(6): e84.
15. Burillo-Putze G, Aldea A, Rodríguez C, García MM, Climent B, Dueñas A, et al. Drogas Emergentes (II). El fenómeno del pharming. An Sist Sanit Navar 2013; 36: 99-114.
16. Burillo-Putze G, López E, Climent B, Munné P, Nogué S, Pinillos MA, Hoffman RS. Emergent Drugs (III): hallucinogenic plants and mushrooms. Anales del sistema sanitario de Navarra 2013; 36(3): 508-518.
17. Bronstein AC, Spyker DA, Cantilena LR, Green JL, Rumack BH, Dart RC. Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 28th Annual Report. Clin Toxicol (Phila) 2011; 49: 910-941.
18. Lajús G, Marrero SE, Leal M, Valle DM. Actualidad en Salud Mental en el CENSAM. Mesa Redonda realizada en el Centro Nacional de Salud Mental del MININT en el marco del 50 Aniversario del CENSAM. [CD-ROM: Memorias de Salud Mental 2015, ISBN 978-959-306-156- 8], CENSAM, Nov 27, 2015.
19. Mathur BN. The claustrum in review. Front Syst Neurosci 2014; 8:48.
20. Burillo-Putze G, Climent B, Medina L, Toledo A. Las smart-drugs: un nuevo reto clínico en urgencias y emergencias. Emergencias 2010; 22: 472-480.
21. Burillo-Putze G, García BC, González AM. Uso de nuevos cannabinoides (Spice) y su detección en Urgencias. An Pediatr (Barc) 2010; 73: 287-288.
22. Smart & headshop. Disponible en: http://www.azarius.net. Consultado 16/02/2018.
23. Palmer, A. El problema de la dependencia en Europa. Luxemburgo: Oficina de publicaciones de la Unión Europea 2012. Recuperado de: http://www.emcdda.europa.eu. Consultado: 16/05/2018.
24. Psychoactive plants and drugs. Disponible en: http://www.erowid.org/psychoactives/psychoactives.shtml. Consultado: 16/03/2018.
25. Mondón S, Nogué S, Urbano D, Rovira E. Adicción a la gabapentina. Med Clin (Barc) 2010; 134:138-139.
26. Oficina de publicaciones de la Unión Europea. Proposal for a council decision on subjecting 5-(2- aminopropyl) indole to control measures. European Commission (2013), Luxemburgo. Disponible en: http://energycontrol.org/. Consultado: 22/06/2018.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Licensing
Ninety Nine Publication publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
